Exomedica is a unique business founded in 2005 to develop and exploit the best of academic and clinical research in the field of Medical Technology.
Exomedica's role is to develop and fund medical technology innovation from its earliest stage including patenting, product design, clinical trials and regulation. Any medical innovation that is in a development phase is of interest to us. We focus on technology deriving from academic and clinical research but also welcome technologies from entrepreneurs and from outside the UK.
Exomedica's role is to develop a technology to the point where value can be realised through a license or asset sale to medical companies and, sometimes, flotation.
The current technology portfolio includes leading innovations in diagnostics and devices for oncology, fertility, orthopaedics, cardiovascular disease, obstetrics and woundcare.
Finance Wales invests in Oncomorph
09th April 2009 : Finance Wales have agreed an investment into Oncomorph, the MRI prostate cancer technology jointly developed by Exomedica and Aberystwyth University and originating from IP jointly held with the Unive...


